NCT01148472View on ClinicalTrials.gov

Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

294

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

November 30, 2006

Conditions
Major Depressive Disorder
Interventions
DRUG

Escitalopram

20mg once daily; orally

DRUG

Duloxetine

60mg once daily; orally

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT01148472 - Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter